Literature DB >> 30945134

Colon 26 adenocarcinoma (C26)-induced cancer cachexia impairs skeletal muscle mitochondrial function and content.

Daria Neyroud1, Rachel L Nosacka2, Andrew R Judge2, Russell T Hepple2.   

Abstract

The present study aimed to determine the impact of colon 26 adenocarcinoma (C26)-induced cancer cachexia on skeletal muscle mitochondrial respiration and content. Twelve male CD2F1 mice were injected with C26-cells (tumor bearing (TB) group), whereas 12 age-matched mice received PBS vehicle injection (non-tumor bearing (N-TB) group). Mitochondrial respiration was studied in saponin-permeabilized soleus myofibers. TB mice showed lower body weight (~ 20%) as well as lower soleus, gastrocnemius-plantaris complex and tibialis anterior masses versus N-TB mice (p < 0.05). Soleus maximal state III mitochondrial respiration was 20% lower (10 mM glutamate, 5 mM malate, 5 mM adenosine diphosphate; p < 0.05) and acceptor control ratio (state III/state II) was 15% lower in the TB vs. N-TB (p < 0.05), with the latter suggesting uncoupling. Lower VDAC protein content suggested reduced mitochondrial content in TB versus N-TB (p < 0.05). Skeletal muscle in C26-induced cancer cachexia exhibits reductions in: maximal mitochondrial respiration capacity, mitochondrial coupling and mitochondrial content.

Entities:  

Keywords:  Mitochondrial content; Mitochondrial coupling; Mitochondrial homeostasis; Mitochondrial respiration; Muscle wasting; Oxidative phosphorylation

Mesh:

Year:  2019        PMID: 30945134      PMCID: PMC6692893          DOI: 10.1007/s10974-019-09510-4

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  27 in total

1.  Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients.

Authors:  I Bosaeus; P Daneryd; E Svanberg; K Lundholm
Journal:  Int J Cancer       Date:  2001-08-01       Impact factor: 7.396

Review 2.  Definition and classification of cancer cachexia: an international consensus.

Authors:  Kenneth Fearon; Florian Strasser; Stefan D Anker; Ingvar Bosaeus; Eduardo Bruera; Robin L Fainsinger; Aminah Jatoi; Charles Loprinzi; Neil MacDonald; Giovanni Mantovani; Mellar Davis; Maurizio Muscaritoli; Faith Ottery; Lukas Radbruch; Paula Ravasco; Declan Walsh; Andrew Wilcock; Stein Kaasa; Vickie E Baracos
Journal:  Lancet Oncol       Date:  2011-02-04       Impact factor: 41.316

3.  Muscle oxidative capacity during IL-6-dependent cancer cachexia.

Authors:  James P White; Kristen A Baltgalvis; Melissa J Puppa; Shuichi Sato; John W Baynes; James A Carson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-09       Impact factor: 3.619

4.  Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency?

Authors:  Cibely Cristine Fontes-Oliveira; Sílvia Busquets; Míriam Toledo; Fabio Penna; Maria Paz Aylwin; Sònia Sirisi; Ana Paula Silva; Marcel Orpí; Albert García; Angelica Sette; Maria Inês Genovese; Mireia Olivan; Francisco J López-Soriano; Josep M Argilés
Journal:  Biochim Biophys Acta       Date:  2013-03

5.  Diaphragm and ventilatory dysfunction during cancer cachexia.

Authors:  Brandon M Roberts; Bumsoo Ahn; Ashley J Smuder; Monsour Al-Rajhi; Luther C Gill; Adam W Beharry; Scott K Powers; David D Fuller; Leonardo F Ferreira; Andrew R Judge
Journal:  FASEB J       Date:  2013-03-20       Impact factor: 5.191

Review 6.  Mitochondrial biogenesis and fragmentation as regulators of muscle protein degradation.

Authors:  Vanina Romanello; Marco Sandri
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

7.  IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse.

Authors:  James P White; Melissa J Puppa; Shuichi Sato; Song Gao; Robert L Price; John W Baynes; Matthew C Kostek; Lydia E Matesic; James A Carson
Journal:  Skelet Muscle       Date:  2012-07-06       Impact factor: 4.912

8.  Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting.

Authors:  Angie M Y Shum; Theodore Mahendradatta; Ryland J Taylor; Arran B Painter; Melissa M Moore; Maria Tsoli; Timothy C Tan; Stephen J Clarke; Graham R Robertson; Patsie Polly
Journal:  Aging (Albany NY)       Date:  2012-02       Impact factor: 5.682

9.  Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia.

Authors:  Caterina Constantinou; Cibely Cristine Fontes de Oliveira; Dionyssios Mintzopoulos; Silvia Busquets; Jianxin He; Meenu Kesarwani; Michael Mindrinos; Laurence G Rahme; Josep M Argilés; A Aria Tzika
Journal:  Int J Mol Med       Date:  2010-11-10       Impact factor: 4.101

10.  Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice.

Authors:  Clara Fermoselle; Elena García-Arumí; Ester Puig-Vilanova; Antoni L Andreu; Alejandro J Urtreger; Elisa D Bal de Kier Joffé; Alberto Tejedor; Luís Puente-Maestu; Esther Barreiro
Journal:  Exp Physiol       Date:  2013-04-26       Impact factor: 2.969

View more
  8 in total

Review 1.  Muscle alterations in the development and progression of cancer-induced muscle atrophy: a review.

Authors:  Megan E Rosa-Caldwell; Dennis K Fix; Tyrone A Washington; Nicholas P Greene
Journal:  J Appl Physiol (1985)       Date:  2019-11-14

2.  Pectoralis major muscle atrophy is associated with mitochondrial energy wasting in cachectic patients with gastrointestinal cancer.

Authors:  Adeline Dolly; Thierry Lecomte; Nicolas Tabchouri; Morgane Caulet; Nicolas Michot; Benjamin Anon; Romain Chautard; Yoann Desvignes; Mehdi Ouaissi; Gaëlle Fromont-Hankard; Jean-François Dumas; Stéphane Servais
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-03-22       Impact factor: 12.063

3.  Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle.

Authors:  Rachel L Nosacka; Andrea E Delitto; Dan Delitto; Rohan Patel; Sarah M Judge; Jose G Trevino; Andrew R Judge
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-02-10       Impact factor: 12.910

Review 4.  Mitochondrial Dysfunction Is a Common Denominator Linking Skeletal Muscle Wasting Due to Disease, Aging, and Prolonged Inactivity.

Authors:  Hayden W Hyatt; Scott K Powers
Journal:  Antioxidants (Basel)       Date:  2021-04-11

5.  Voluntary exercise prevents abnormal muscle mitochondrial morphology in cancer cachexia mice.

Authors:  Yu Kitaoka; Mitsunori Miyazaki; Shin Kikuchi
Journal:  Physiol Rep       Date:  2021-08

6.  Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia.

Authors:  Elisabeth Wyart; Myriam Y Hsu; Alessio Menga; Paolo E Porporato; Roberta Sartori; Erica Mina; Valentina Rausch; Elisa S Pierobon; Mariarosa Mezzanotte; Camilla Pezzini; Laure B Bindels; Andrea Lauria; Fabio Penna; Emilio Hirsch; Miriam Martini; Massimiliano Mazzone; Antonella Roetto; Simonetta Geninatti Crich; Hans Prenen; Marco Sandri
Journal:  EMBO Rep       Date:  2022-02-24       Impact factor: 8.807

7.  Baoyuan Jiedu decoction alleviating cancer cachexia-Induced muscle atrophy by regulating muscle mitochondrial function in Apc Min/+ mice.

Authors:  Beiying Zhang; Qianyu Bi; Shengqi Huang; Siyuan Lv; Xin Zong; Mengran Wang; Xuming Ji
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

Review 8.  Molecular mechanisms of cancer cachexia‑induced muscle atrophy (Review).

Authors:  Wei Yang; Jianhui Huang; Hui Wu; Yuqing Wang; Zhiyin Du; Yuanbo Ling; Weizhuo Wang; Qian Wu; Wenbin Gao
Journal:  Mol Med Rep       Date:  2020-10-16       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.